DWK Life Sciences GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DWK Life Sciences GmbH - overview
Established
2005
Location
Wertheim, -, Germany
Primary Industry
Medical Devices & Equipment
About
Based in Germany, DWK Life Sciences GmbH specializes in delivering high-quality glassware and packaging solutions for the pharmaceutical, diagnostic, and laboratory sectors, enhancing safety and efficiency in scientific applications. DWK Life Sciences GmbH is engaged in the production of glassware and packaging for various scientific sectors. Founded in 2005, the company's headquarters is located in Wertheim, Germany. The current CEO is Armin Reiche, who leads the company in its mission to provide innovative lab solutions.
DWK Life Sciences specializes in providing comprehensive glassware and packaging solutions tailored to the pharmaceutical, diagnostic, and laboratory sectors. Their core offerings include a diverse range of laboratory bottles, vials, and sample containers, designed to ensure safety and reliability during use. The products are meticulously crafted to meet the stringent requirements of various applications, such as drug development, analytical sciences, and laboratory essentials. DWK’s innovative solutions, including the EZ-fill® platform tailored for ready-to-use applications, enhance operational efficiency for pharmaceutical companies.
The company serves a global clientele spanning North America, Europe, Asia, and other regions, catering to laboratory professionals and businesses engaged in drug research, development, and analysis. In 2023, DWK Life Sciences reported a revenue of USD 105. 72 mn and an EBITDA of USD 11. 51 mn.
The company generates revenue primarily through direct sales of its glassware and packaging products to B2B clients, including pharmaceutical companies, research laboratories, and diagnostic facilities. This established model allows DWK to maintain a stable revenue flow while addressing diverse customer needs across international markets. DWK Life Sciences is focused on expanding its product offerings and entering new markets. The company is currently designing new variations of its EZ-fill® system, with anticipated launches planned for mid-2024.
Additionally, DWK plans to expand its presence in Asia and South America, aiming for entry into these markets by late 2024. Recent funding will be utilized to support these initiatives, enhancing R&D capabilities and marketing efforts to increase brand awareness in the targeted regions.
Current Investors
One Equity Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies, Packaging, Glass
Website
www.dwk.com/
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
DWK Life Sciences GmbH - timeline of key events
DWK Life Sciences GmbH - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 72,527,199 | 74,042,785 | 76,789,335 | 74,366,377 | 75,639,971 | 80,995,877 | 88,836,334 | 91,870,070 | 83,675,540 | 85,196,604 | 80,353,282 | 92,788,815 | - | - | - |
| % Revenue Growth (YoY) | - | 2.1% | 3.7% | (3.2%) | 1.7% | 7.1% | 9.7% | 3.4% | (8.9%) | 1.8% | (5.7%) | 15.5% | - | - | - |
| EBITDA (USD) | 10,744,996 | 11,776,107 | 10,355,645 | 20,838,432 | 9,115,974 | 12,566,867 | 13,489,830 | 13,142,039 | 12,190,575 | 6,729,756 | 8,144,106 | 12,939,799 | - | - | - |
| Operating Income (USD) | 10,205,884 | 11,293,710 | 9,938,990 | 20,515,914 | 8,859,419 | 12,336,387 | 13,221,939 | 12,714,014 | 11,697,367 | 5,686,793 | 7,048,322 | 11,932,652 | - | - | - |
| Operating Margin | 14.1% | 15.3% | 12.9% | 27.6% | 11.7% | 15.2% | 14.9% | 13.8% | 14.0% | 6.7% | 8.8% | 12.9% | - | - | - |
| % EBITDA Margin | 14.8% | 15.9% | 13.5% | 28.0% | 12.1% | 15.5% | 15.2% | 14.3% | 14.6% | 7.9% | 10.1% | 13.9% | - | - | - |
| NET Income (USD) | 9,644,091 | 10,742,623 | 9,516,134 | 19,528,685 | 8,092,807 | 11,187,169 | 12,448,843 | 11,245,357 | 9,029,360 | 3,173,124 | 4,289,508 | 9,521,626 | - | - | - |
| % Net Margin | 13.3% | 14.5% | 12.4% | 26.3% | 10.7% | 13.8% | 14.0% | 12.2% | 10.8% | 3.7% | 5.3% | 10.3% | - | - | - |
DWK Life Sciences GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Assem-Pak Corporation | - | ||||||||
| Add-on | Completed | Müller + Müller-Joh. GmbH + Co. KG | - | ||||||||
| Add-on | Completed | Kimble Chase Life Science and Research Products LLC | - | ||||||||
| Add-on, Trade Sale | Completed | Wheaton Industries Inc. | - | ||||||||
| Company Formation | Completed | DWK Life Sciences GmbH | - |
Displaying 1 - 5 of 6
DWK Life Sciences GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.